leisure time -WSS

leisure time

author：explore 2025-10-01 11:33:17 - browse：14731

Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered by a form of CRISPR called base editing showed reductions in bad cholesterol levels — study results that are preliminary but signal the potential for gene-editing treatments to benefit people with an inherited type of cardiovascular disease.

Three of the study participants treated with potentially therapeutic doses of the Verve drug, called VERVE-101, showed reductions in LDL-C levels of 39%, 48%, and 55%, respectively. The latter patient’s decline in so-called “bad” cholesterol was maintained for six months.

The Verve-101 study results were presented at the American Heart Association conference and are the first data in patients from a therapy that uses base editing to change individual letters of DNA. Verve licensed the base-editing technology from Beam Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

hotspot

knowledge

WSS

Why the world’s most expensive drug might be worth the price

Primary care physicians play key roles in Alzheimer's management

Food as medicine: Medically tailored meals may get standardized

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

HCA says smaller share of spending going to labor

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

hotspot

leisure time

leisure time

Hepatitis C has a cure — but many Americans still lack access to it

House GOP plan to stem drug shortages differs from Democrats’

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Vertex Pharmaceuticals may move headquarters in Boston

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

States should stop sabotaging methadone treatment reform

Medical leaders decry Supreme Court decision on affirmative action

Steward Health Care has deal to sell doctor network to UnitedHealth

Novavax promises a turnaround & Lilly roils the obesity market

Why the world’s most expensive drug might be worth the price

Wikipedia

Europe is fastest

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Campaign finance charge dropped from case against Sam Bankman

'Weather

'Weather

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

hotspot

knowledge

leisure time

focus